Faron Pharmaceuticals Oy (FARN.LSE) Q3 2025 Earnings

27AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-18.54
-15.38
-12.21
-9.04

Details

Expected EPS
-9.366019966793491
Actual EPS
-13.241027864424359
Surprise EPS
-3.88
Surprise Percent
+41.37%

Description

Faron Pharmaceuticals Oy (FARN.LSE) has reported earnings of -13.241027864424359 per share for Q3 2025.

0 Comments

Share your thoughts